Completed PHASE3 INTERVENTIONAL 2-arm NCT02635204

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days

Sponsor: Promius Pharma, LLC

Conditions Psoriasis

Interventions DFD06 Cream Vehicle Cream

Updated 7 times since 2017 Last updated: Apr 13, 2018 Started: Dec 31, 2015 Primary completion: Jul 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Psoriasis, this trial is completed. The trial is conducted by Promius Pharma, LLC and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
May 2018 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — May 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Promius Pharma, LLC

Data source: Promius Pharma, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Arlington, United States , Arlington Heights, United States , Beverly, United States , Brandon, United States , Cincinnati, United States , Coral Gables, United States , Dallas, United States , Denver, United States , Fountain Valley, United States , Glendale, United States and 19 more locations